🔗 Permalink

Inventor profile of:

Ivan Lieberburg

City:

Berkeley, California

Country:

United States

Published Applications:

Last publication date:

2024-12-05

Top Assignees for applications by Ivan Lieberburg

The entities that hold a legal rights for patent applications filed by inventor Lieberburg Ivan:

EISAI CO., LTD. 8 Tokyo, Japan
Wyeth LLC 6 Madison, NJ United States
ELAN PHARMACEUTICALS, INC. 5 South San Francisco, CA United States
Janssen Alzheimer Immunotherapy 2 Little Island, County Cork, Ireland
Janssen Alzheimer Immunotherapy 2 , Ireland
BIOGEN MA INC. 2 Cambridge, MA United States
JANSSEN SCIENCES IRELAND UC 2 , Ireland
Janssen Alzheimer Immunotherapy 2 Little Island, Ireland
JANSSEN ALZHEIMER IMMUNOTHERAPY 2 Dublin 2, Ireland
Biogen Idec MA Inc. 1 Cambridge, MA United States
Wyeth 1 Madison, NJ United States
JANSSEN SCIENCES IRELAND UC 1 County Cork, Ireland
Elan Pharma International Limited 1 Athlone, Ireland
BIOGEN INC. 1 Cambridge, MA United States

Recent patent applications by Lieberburg Ivan

Ivan Lieberburg from Berkeley, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-12-05

US20240400694A1

Chemistry; metallurgy

METHODS OF TREATING INFLAMMATORY AND AUTOIMMUNE DISEASES

#2 | 2019-10-17

US20190315871A1

Chemistry; metallurgy

Methods of treating inflammatory and autoimmune diseases with natalizumab

#3 | 2017-08-31

US20170247457A1

Chemistry; metallurgy

Methods of treating inflammatory and autoimmune diseases with natalizumab

#4 | 2017-01-26

US20170022276A1

Chemistry; metallurgy

METHODS OF TREATING INFLAMMATORY AND AUTOIMMUNE DISEASES WITH NATALIZUMAB

#5 | 2015-04-30

US20150118223A9

Human necessities

Use of tau to monitor immunotherapy

#6 | 2015-02-26

US20150056205A1

Chemistry; metallurgy

STEROID SPARING AGENTS AND METHODS OF USING SAME

#7 | 2014-02-20

US20140051655A1

Human necessities

METHODS OF TREATING INFLAMMATORY AND AUTOIMMUNE DISEASES WITH ALPHA-4 INHIBITORY COMPOUNDS

#8 | 2013-08-15

US20130209453A1

Human necessities

USE OF TAU TO MONITOR IMMUNOTHERAPY

#9 | 2012-03-22

US20120070379A1

Chemistry; metallurgy

IMMUNOTHERAPY REGIMES DEPENDENT ON APOE STATUS

#10 | 2011-09-22

US20110229413A1

Chemistry; metallurgy

Treatment of amyloidogenic diseases

#11 | 2010-10-21

US20100266505A1

Chemistry; metallurgy

Immunotherapy regimes dependent on ApoE status

#12 | 2010-09-02

US20100221187A1

Chemistry; metallurgy

Treatment of amyloidogenic diseases

#13 | 2010-08-05

US20100196318A1

Chemistry; metallurgy

Methods of treating inflammatory and autoimmune diseases with natalizumab

#14 | 2009-12-17

US20090312353A1

Human necessities

Methods and compositions for treating liquid tumors

#15 | 2009-06-18

US20090155256A1

Chemistry; metallurgy

Immunotherapy Regimes Dependent On APOE Status

#16 | 2008-04-17

US20080089861A1

Human necessities

Combination therapy for treatment of demyelinating conditions

#17 | 2008-02-21

US20080044382A1

Human necessities

Methods of treating inflammatory and autoimmune diseases with alpha-4 inhibitory compounds

#18 | 2007-09-06

US20070207141A1

Chemistry; metallurgy

Methods of treating inflammatory and autoimmune diseases with natalizumab

#19 | 2006-01-05

US20060004019A1

Human necessities

Steroid sparing agents and methods of using same

#20 | 2005-11-24

US20050260193A1

Chemistry; metallurgy

Steroid sparing agents and methods of using same

#21 | 2005-07-14

US20050154037A1

Human necessities

Methods of using zonisamide as an adjunctive therapy for partial seizures

#22 | 2005-07-14

US20050154036A1

Human necessities

Methods of using zonisamide as an adjunctive therapy for partial seizures

#23 | 2005-07-14

US20050154035A1

Human necessities

Methods of using zonisamide as an adjunctive therapy for partial seizures

#24 | 2005-07-14

US20050154034A1

Human necessities

Methods of using zonisamide as an adjunctive therapy for partial seizures

#25 | 2005-07-14

US20050154033A1

Human necessities

Methods of using zonisamide as an adjunctive therapy for partial seizures

#26 | 2005-07-14

US20050154032A1

Human necessities

Methods of using zonisamide as an adjunctive therapy for partial seizures

#27 | 2005-04-07

US20050074451A1

Human necessities

Methods and compositions for treating rheumatoid arthritis

#28 | 2005-03-24

US20050065192A1

Human necessities

Methods and compositions for treating rheumatoid arthritis

#29 | 2005-03-17

US20050059718A1

Human necessities

Methods of using zonisamide as an adjunctive therapy for partial seizures

#30 | 2005-02-24

US20050043773A1

Human necessities

Methods of improving the safety of zonisamide therapy

#31 | 2005-02-24

US20050043705A1

Human necessities

Methods of using zonisamide as an adjunctive therapy for partial seizures

#32 | 2005-02-24

US20050043704A1

Human necessities

Methods of using zonisamide as an adjunctive therapy for partial seizures

InventorID:

388472 ⎘